Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life

Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/RMDOPEN-2018-000755
P932PMC publication ID6241970
P698PubMed publication ID30487997

P50authorMaxime DougadosQ63136268
Astrid van TubergenQ83113550
Annelies BoonenQ91062233
Sofia RamiroQ39184066
Robert LandewéQ47264015
P2093author name stringFilip Van den Bosch
Anneke Spoorenberg
Suzanne Arends
Valéria Lima Passos
Desirée van der Heijde
Freke R Wink
Maike Imkamp
P2860cites workEvaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre studyQ47355075
Which aspects of health are most important for patients with spondyloarthritis? A Best Worst Scaling based on the ASAS Health IndexQ47418606
Comorbidities in Spondyloarthritis associate with poor function, work disability and quality of life: Results from the ASAS-COMOSPA study.Q47617915
Social role participation and satisfaction with life: A study among patients with ankylosing spondylitis and population controlsQ47819749
Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohortQ48572011
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.Q51848130
Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis.Q53037194
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.Q53212276
Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitisQ79696620
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scoresQ82414520
The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort studyQ87497578
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Q24186403
TNF-alpha inhibitors for ankylosing spondylitisQ24186462
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitisQ24674389
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity IndexQ28299001
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitisQ33860755
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteriaQ34055060
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional IndexQ34307327
Predicting the outcome of ankylosing spondylitis therapyQ34905433
Socioeconomic consequences of ankylosing spondylitisQ35015332
Withdrawal from labour force due to work disability in patients with ankylosing spondylitisQ35549928
Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort studyQ35557916
Five Potentially Modifiable Factors Predict Poor Quality of Life in Ankylosing Spondylitis: Results from the Scotland Registry for Ankylosing Spondylitis.Q38648071
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task forceQ38690324
Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis of 234 PatientsQ39097247
The co-occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: Results from a UK national register (BSRBR-AS).Q40157050
Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort.Q40456866
Quality of life and correlation with clinical and radiographic variables in patients with ankylosing spondylitis: a retrospective case series study.Q41431578
Introducing the fit-criteria assessment plot - A visualisation tool to assist class enumeration in group-based trajectory modellingQ41490584
Role of contextual factors in health-related quality of life in ankylosing spondylitisQ44781334
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectquality of lifeQ13100823
P304page(s)e000755
P577publication date2018-01-01
P1433published inRMD openQ27726913
P1476titleUncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life
P478volume4

Search more.